Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application…
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Roche RHHBY announced that the FDA has accepted and granted priority review to its supplemental biologics license application…